Separately, one of the other reasons I decided on PGNX was after doing a little more DD, I found out that one caveat has been that PGNX has Phase 2 data on oral Relistor but has not released that data. The bearish case is that the data is bad so PGNX doesn't want to release it. However, during the Salix CC, Salix confirmed that it had seen the Phase 2 oral Relistor data and was "quite impressed."
Oral Relistor development, unlike subc Relistor, was completely controlled by Wyeth. PGNX didn't get full data transferred to them until sometimes in 2010. So it is not surprising they haven't presented the data yet. Wyeth did announce positive result when the trial was done, so I wouldn't doubt the data. Besides PGNX already initiated phase III trial.
Market Data 
Markets 
AI
